Clinica Baviera (XMAD:CBAV) EPS (Basic): €2.74 (TTM As of Mar. 2026)


XMAD:CBAV Clinica Baviera SA XMAD:CBAV
100 GF Score
Price €56.60
GF Value €41.29
Valuation Significantly Overvalued
! 4 Warning Signs
View Full Analysis

What is Clinica Baviera EPS (Basic)?

Clinica Baviera XMAD:CBAV +0.71% 100 EPS (Basic) is €2.74 as of Mar. 2026. GuruFocus rates XMAD:CBAV with a GF Score™ of 100/100 and a GF Value™ of €41.29 (Significantly Overvalued). The stock has 4 warning signs investors should review.

Clinica Baviera's basic earnings per share (Basic EPS) for the three months ended in Mar. 2026 was €0.92. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Mar. 2026 was €2.74.

Clinica Baviera's EPS (Diluted) for the three months ended in Mar. 2026 was €0.92. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 was €2.74.

Clinica Baviera's EPS without NRI for the three months ended in Mar. 2026 was €0.92. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Mar. 2026 was 2.74.

During the past 12 months, Clinica Baviera's average EPS without NRIGrowth Rate was 8.30% per year. During the past 3 years, the average EPS without NRI Growth Rate was 12.30% per year. During the past 5 years, the average EPS without NRI Growth Rate was 21.70% per year. During the past 10 years, the average EPS without NRI Growth Rate was 24.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 13 years, Clinica Baviera's highest 3-Year average EPS without NRI Growth Rate was 38.50% per year. The lowest was -46.50% per year. And the median was 12.55% per year.

Clinica Baviera  (XMAD:CBAV) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

Clinica Baviera EPS (Basic) Related Terms

Clinica Baviera EPS (Basic) Historical Data

* Premium members only.

The historical data trend for Clinica Baviera's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Clinica Baviera EPS (Basic) Chart

Clinica Baviera Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
EPS (Basic)
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.68 1.81 2.21 2.47 2.63

Clinica Baviera Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
EPS (Basic) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.80 0.59 0.37 0.86 0.92
XMAD:CBAV
100GF Score
Clinica Baviera SA XMAD:CBAV
EPS (Basic) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Clinica Baviera EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

Clinica Baviera's Basic EPS for the fiscal year that ended in Dec. 2025 is calculated as

Basic EPS (A: Dec. 2025 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(42.063-0)/16.014
=2.63

Clinica Baviera's Basic EPS for the quarter that ended in Mar. 2026 is calculated as

Basic EPS (Q: Mar. 2026 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(14.7-0)/16.025
=0.92

EPS (Basic) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €2.74

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EPS (Basic) →
What does a EPS (Basic) of €2.74 mean?
Clinica Baviera (XMAD:CBAV) has a EPS (Basic) of €2.74 as of Mar. 2026. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on Clinica Baviera and its competitors.
Is Clinica Baviera's EPS (Basic) too high?
Clinica Baviera's current EPS (Basic) is €2.74. Overall, Clinica Baviera has a GF Score™ of 100/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Clinica Baviera's EPS (Basic) compare to TMO and DHR?
Clinica Baviera's EPS (Basic) of €2.74 can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EPS (Basic) for a Medical Diagnostics & Research company?
A good EPS (Basic) depends on the Medical Diagnostics & Research industry context. However, EPS (Basic) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EPS (Basic) mean?
A high EPS (Basic) can signal that a stock is expensive relative to its fundamentals. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on Clinica Baviera and its competitors. Clinica Baviera's current EPS (Basic) is €2.74. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Clinica Baviera stock overvalued right now?
Based on GuruFocus' analysis, Clinica Baviera (XMAD:CBAV) is currently considered Significantly Overvalued. The stock's GF Value™ is €41.29, compared to a current price of €56.60 — trading 37.1% above its estimated fair value. The current EPS (Basic) is €2.74. Clinica Baviera's overall GF Score™ is 100/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EPS (Basic) calculated?
EPS (Basic) is calculated from a company's financial statements. For Clinica Baviera (XMAD:CBAV), the current EPS (Basic) is €2.74 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Clinica Baviera (XMAD:CBAV) Overvalued in 2026?

Based on GuruFocus' analysis, Clinica Baviera stock appears to be overvalued. The current stock price of €56.60 is trading 37.1% above its estimated GF Value™ of €41.29. GuruFocus considers Clinica Baviera to be Significantly Overvalued.

Key valuation signals for XMAD:CBAV:

  • EPS (Basic): €2.74
  • GF Value™: €41.29 vs. price of €56.60 (37.1% above fair value)
  • GF Score™: 100/100 with 4 warning signs

No single metric tells the full story. See the XMAD:CBAV stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Clinica Baviera Business Description

Other Exchanges 0GWJ:UKD9Z:Germany
Address Paseo de la Castellana 20, Madrid, ESP, 28046
Clinica Baviera SA operates ophthalmological clinics. It is involved in the diagnosis, treatment, and monitoring of various types of ophthalmological disorders. It offers diagnosis and treatment for various eye problems such as long-sightedness, short-sightedness, astigmatism, cataracts and eye strain.
100GF Score

Get the complete analysis for XMAD:CBAV

EPS (Basic) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€56.60
Price
€41.29
GF Value